Bond AbbVie Inc. 4.4% ( USU0029QAD89 ) in USD
| Issuer | AbbVie Inc. |
| Market price | |
| Country | United States
|
| ISIN code |
USU0029QAD89 ( in USD )
|
| Interest rate | 4.4% per year ( payment 2 times a year) |
| Maturity | 06/11/2042 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 2 600 000 000 USD |
| Cusip | U0029QAD8 |
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
| Moody's rating | N/A |
| Next Coupon | 06/11/2025 ( Tomorrow ) |
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. AbbVie issued a USD 2,600,000,000 bond (CUSIP: U0029QAD8, ISIN: USU0029QAD89) maturing on 06/11/2042, currently trading at 100% with a 4.4% coupon rate, paying semi-annually, and rated BBB+ by S&P, with a minimum purchase amount of 2,000. |
Français
Italiano
United States